MIMETAS Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Leiden, Netherlands
Total Funding:N/A
Industry:Biotech
Founded:2013
Lead Investor(s):N/A

Estimated Revenue & Financials

  • MIMETAS's estimated annual revenue is currently $15.2M per year.(?)
  • MIMETAS's estimated revenue per employee is $155,000

Employee Data

  • MIMETAS has 98 Employees.(?)
  • MIMETAS grew their employee count by 56% last year.
  • MIMETAS currently has 1 job openings.

High-throughput Human Disease and Tissue Models MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.

keywords:N/A